Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer
Characterization of Peripheral Muscle Function in Patients With Non-small-cell Lung Cancer.
Rationale: With 1.6 million new cases diagnosed each year and 1.3 million deaths, lung cancer is the leading cancer-related death worldwide and it represents a pressing health issue. Patients with lung cancer are more likely to experience cachexia, a severe debilitating disorder causing fatigue, weight loss, muscle wasting and associated with reduced physical function, increased chemotherapy toxicity and reduced survival. This syndrome occurring in about 80% of advanced cancer patients is the direct cause of death in about 20% of cases. However, despite the importance of cachexia in lung cancer, its mechanisms ans its relation with muscle function and effort tolerance are still unknown.
Aim: To explore muscle function, signaling pathways and its relationship to impaired functional capacity of patients with non-small-cell lung cancer(NSCLC); depending of whether they have cachexic state at diagnosis.
Methods: This study will be conducted at the Institut universitaire de cardiologie et de pneumologie de Québec. 56 patients newly diagnosed of NSCLC will be recruited and separated whether or not they have a cachexic state. The evaluation will need two visits separated by 5 days.
During the evaluation the following tests will be done:
- Anthropometric measures
- Level of daily physical activity
- Pulmonary function test
- Maximal incremental cardiopulmonary exercise test on ergocycle
- Endurance test on ergocycle
- Muscle function tests
- Magnetic stimulation
- Quadriceps biopsy
研究概览
地位
研究类型
注册 (预期的)
联系人和位置
学习地点
-
-
Quebec
-
Québec、Quebec、加拿大、G1V 4G5
- 招聘中
- Institut Universitaire de cardiologie et de pneumologie de Quebec
-
接触:
- Didier Saey, PhD
- 电话号码:2614 418-656-8711
- 邮箱:didier.saey@criucpq.ulaval.ca
-
首席研究员:
- Didier Saey, PhD
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
取样方法
研究人群
描述
Inclusion Criteria:
- Men and women with a primary lung cancer diagnosis
Exclusion Criteria:
- Already have undertaken surgery, chemotherapy or radiotherapy treatment
- Having an other cancer in the last five years
- Taking anticoagulation therapy
学习计划
研究是如何设计的?
设计细节
队列和干预
团体/队列 |
|---|
|
Lung cancer patient with cachexia
Muscle lumbar area < 55cm2/m2 for men and < 39 cm2/m2 for women
|
|
Lung cancer patients without cachexia
Muscle lumbar area over 55cm2/m2 for men and 39 cm2/m2 for women
|
研究衡量的是什么?
主要结果指标
结果测量 |
大体时间 |
|---|---|
|
Maximal quadriceps strength
大体时间:1 day (at the time of the diagnosis before any treatment)
|
1 day (at the time of the diagnosis before any treatment)
|
次要结果测量
结果测量 |
大体时间 |
|---|---|
|
Exercise capacity
大体时间:1 day (at the time of the diagnosis before any treatment)
|
1 day (at the time of the diagnosis before any treatment)
|
合作者和调查者
调查人员
- 首席研究员:Didier Saey, PhD、Institut universitaire de cardiologie et de pneumologie de Québec, University Laval
研究记录日期
研究主要日期
学习开始
初级完成 (预期的)
研究完成 (预期的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (估计)
研究记录更新
最后更新发布 (估计)
上次提交的符合 QC 标准的更新
最后验证
更多信息
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.